TY - CHAP AU - Thomas J. FitzGerald AU - Linda Ding AU - Christopher Riberdy AU - Jack Bailey AU - Michael Anderegg AU - Ameer Elaimy AU - James Shen AU - Kevin O’Connor AU - Carla Bradford AU - I-Lin Kuo AU - Yankhua Fan AU - Fenghong Liu AU - Suhong Yu AU - Harry Bushe AU - Jonathan Saleeby AU - Paul Rava AU - Shirin Sioshansi AU - M. Giulia Cicchetti AU - Janaki Moni AU - Eric Ko AU - Allison Sacher AU - Daniel Han AU - Maryann Bishop-Jodoin ED - Thomas J. FitzGerald ED - Maryann Bishop-Jodoin Y1 - 2021-05-20 PY - 2021 T1 - The Future of Proton Therapy N2 - Over the past twenty-five years, proton therapy has become more prominent worldwide. It is an important component of clinical radiation therapy for both adult and pediatric clinical care. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. As such, Proton Therapy - Current Status and Future Directions reviews many aspects of proton care including the application of protons in modern clinical trials. It also reviews problems associated with the migration of proton care worldwide and examines the future direction of proton care. This project was created by colleagues at IntechOpen and was carefully managed by Romina Rovan. It has been a privilege to help coordinate the text and chapters designed to acknowledge the history, footprint, and growing interest of proton care worldwide. Proton management is now embedded in the clinical trials process. In pediatric care, proton delivery is embedded with photons for the management of pediatric malignancies and adult groups have initiated proton-specific clinical trials. A proton registry has been established and outcomes are under evaluation. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. BT - Proton Therapy SP - Ch. 9 UR - https://doi.org/10.5772/intechopen.97935 DO - 10.5772/intechopen.97935 SN - 978-1-83968-013-7 PB - IntechOpen CY - Rijeka Y2 - 2024-03-28 ER -